# Pharmacology Dosing Error Prevention

## Hard-Stop Logic for Narrow-Therapeutic-Index (NTI) Drugs
In pharmacology, the difference between a cure and a poison is the dose. For Narrow-Therapeutic-Index (NTI) drugs (e.g., Warfarin, Digoxin, Lithium), a 10% deviation in dosage can be lethal. The Personalized Pharmacology Engine implements 'Hard-Stop' error handling to prevent AI-driven dosing errors.

## 1. The NTI Registry
The system maintains a registry of all NTI drugs, each with a strictly defined **Therapeutic Window** $[D_{min}, D_{max}]$.

## 2. The Hard-Stop Validation Logic

### 2.1 Absolute Ceiling Check
Regardless of the AI's reasoning or the patient's weight, the system will not authorize any dose $D > D_{max}$. Any attempt to do so triggers an immediate `LETHAL_DOSE_PREVENTION` alert and locks the medication pump.

### 2.2 Rate-of-Change Guardrail
To prevent rapid toxicity, the system limits the rate at which a dose can be increased:
$$\frac{\Delta D}{\Delta t} \le R_{max}$$
If the AI attempts to double a dose within 24 hours for an NTI drug, the system requires a secondary biometric authorization from a human pharmacist.

### 2.3 Cross-Drug Interaction Filter
The AI must check for synergistic toxicity. If the patient is on an NTI drug and the AI recommends a second drug that inhibits the metabolism of the first (e.g., a CYP3A4 inhibitor), the system automatically reduces the NTI dose by the empirically proven interaction factor $eta$.

## 3. Empirical Evidence
By implementing these deterministic hard-stops, we eliminate the possibility of 'AI-hallucinated' dosages, ensuring that the precision of the AI is tempered by the absolute safety of pharmacological laws.